Azure Healthcare Ltd (ASX:AZV) will be losing a key person, Nathan Buzza, who was responsible for overseeing the development of the software that is now revolutionising the business. As I previously pointed out, the fact that the company now offers software solutions - not just hardware - is central to the Azure Healthcare investment thesis. Indeed, it was only once Buzza (and founder Robert Grey) both rejoined the company that its fortunes turned around. At least the software has been fully developed, so to an extent, it makes sense that Mr Buzza is now leaving. Having said that, I don't think there is any reason why the company couldn't have put it on their website or issued a press release.

Edit: Please Note this post is now out of date (see comments below) 

Answer: No. The buy thesis is broken by announcement dated 3/6/2014. Update to come.

Some readers might be interested to know a little more about the Discounted Cash Flow model that I use on this website, as it is quite eccentric. I've had a few questions, but to date, no-one has been able to work it out.

The recently listed Beacon Lighting Group Ltd (ASX: BLX) may be of interest. It’s shares were way oversubscribed in the IPO and its share price went up 60% on listing. However, we still see good value at current prices.